Optimize global taxes

Developing effective global tax strategies that address regulatory challenges and enable business success

Pharmaceutical and life sciences companies around the world are facing pressure to develop more effective tax strategies while remaining compliant in a constantly changing regulatory landscape. Tax concerns impact a wide range of areas that include:

Pharma industry trends—such as investing in new technology, collaborating with new entrants, and operating on a global scale—create opportunities for effective tax planning. To remain successful, companies must seek efficient solutions that turn tax data into insights and help transform their tax function into a modern and efficient business enabler.

Playback of this video is not currently available

Kathleen Michael, PwC, US Pharmaceutical and Life Sciences Tax Leader, talks about how tax reform can fuel US pharma R&D

How PwC can help

PwC understands the pharmaceutical market and the global environment in which our clients operate. Our tax specialists provide the full spectrum of support—from tax structuring through co-sourcing and outsourcing. We know how to automate processes so your tax department can focus on adding value and helping to grow business.

And, we’re structured to meet the needs of each key segment, including:

  • Medical device and diagnostics manufacturers
  • Proprietary and generic drug companies
  • Wholesalers and distributors
  • Specialty drug makers
  • Biotechnology companies
  • Pharmacy benefit managers
  • Contract research organizations
  • Industry associations

PwC will help you implement the tax-efficient structures and technology you need to succeed in the global marketplace.

More information on our US Tax practice.


Contact us

Michelle Lee

Michelle Lee

Health Industry & Pharma Life Science Tax Leader, PwC US

Follow us